Why Do I Need NTM Testing Before Long-Term Azithromycin?

If your care team has recommended taking a daily or thrice-weekly macrolide antibiotic (like azithromycin or clarithromycin) for several months or longer to prevent bronchiectasis flare-ups, they will likely ask for a sputum (phlegm) sample first. Guidelines recommend testing this sample specifically for nontuberculous mycobacteria (NTM) before you start a long-term macrolide ^[1][2].

This waiting period is a standard safety step. Taking a single antibiotic long-term when you have an undiagnosed NTM infection can cause the NTM to become highly resistant to treatment ^[1][3]. Because NTM is complex to treat, doctors use this test to protect your future treatment options. (Note: This rule applies to long-term preventative use, not necessarily a short course of antibiotics for a sudden acute respiratory infection).

The Risk of Antibiotic “Monotherapy”

In bronchiectasis care, long-term macrolides are often prescribed to reduce inflammation and lower the number of exacerbations you experience ^[1][4]. Because you are taking only one type of antibiotic for prevention, this is called monotherapy.

While monotherapy can be highly beneficial for selected bronchiectasis patients, it is unsafe if you have an active, untreated NTM infection. NTM is an umbrella term for a group of environmental bacteria (distinct from tuberculosis). If an active NTM lung infection is present, it requires a tailored combination of multiple antibiotics working together—often three or more drugs—to successfully treat it ^[5][6].

When NTM is exposed to just one antibiotic like azithromycin, the medication kills the susceptible bacteria. However, any naturally resistant bacteria that are present will survive, multiply, and become the dominant strain ^[7].

How NTM Resistance Occurs

There are two main ways NTM bacteria can survive macrolide exposure:

• Target-site mutations: Over time, the bacteria can develop mutations in their genetic code (specifically the rrl gene) that alter the shape of the spot where the antibiotic normally attaches ^[8][9]. When this happens, the drug can no longer bind to the bacteria to stop them ^[7].
• Inducible resistance: Certain types of NTM, such as Mycobacterium abscessus, naturally possess a specific gene (the erm(41) gene). This gene can “turn on” when the bacteria are exposed to a macrolide, making them resistant to the drug ^[10][8].

Protecting Your Future Treatment Options

Macrolide antibiotics are considered “cornerstone” treatments for many of the most common NTM species, such as Mycobacterium avium complex (MAC). If an NTM infection becomes resistant to macrolides, future treatment becomes much more complicated ^[3].

Treating macrolide-resistant NTM generally requires longer courses of alternative, sometimes intravenous (IV) antibiotics, and the chances of completely clearing the infection decrease substantially ^[7][11]. In some challenging cases where the infection remains localized but resistant to drugs, patients may even need to be evaluated for lung surgery to remove the damaged tissue ^[12][13]. By screening for NTM first, your doctor ensures these crucial antibiotics will still work if you ever need them to fight an active NTM infection.

Understanding the Testing Process

Providing a sputum sample for NTM (often called a mycobacterial culture) is different from a routine bacterial culture.

• Waiting for results: Some NTM species grow rapidly, but others, like MAC, grow very slowly in the lab. A final negative culture can take anywhere from 6 to 8 weeks ^[14].
• What a negative result means: A negative result significantly lowers the concern for NTM. However, because NTM can be shed intermittently, a single negative sample isn’t an absolute guarantee ^[10]. Your doctor might ask for multiple samples to be sure.
• What a positive result means: A positive culture does not automatically mean you have active NTM lung disease. NTM bacteria are common in the environment, and a positive result might just mean the bacteria are temporarily present (colonization) without causing infection ^[10][15]. If your result is positive, your doctor will look at your symptoms and chest CT scans, and may consult a specialist to decide the best path forward.

Other Safety Checks Before Starting Macrolides

NTM testing is the most specific step before starting long-term azithromycin, but it isn’t the only one. Your clinician will also evaluate if long-term macrolides are safe for you personally. They may check your heart rhythm (using an ECG to watch for QT prolongation), perform liver function blood tests, evaluate you for hearing or balance issues, and review your other medications for drug interactions.

While waiting for your NTM culture results, do not start or stop any antibiotics on your own. Continue with your daily airway clearance techniques and let your care team know if your bronchiectasis symptoms worsen.